TransMedics (TMDX) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | 43.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.72% |
| Dec 31, 2025 | 43.29% |
| Sep 30, 2025 | 43.38% |
| Jun 30, 2025 | 45.01% |
| Mar 31, 2025 | 41.15% |
| Dec 31, 2024 | 30.24% |
| Sep 30, 2024 | 27.87% |
| Jun 30, 2024 | 32.72% |
| Mar 31, 2024 | 35.81% |
| Dec 31, 2023 | 28.44% |
| Sep 30, 2023 | -18.46% |
| Jun 30, 2023 | 64.16% |
| Mar 31, 2023 | 37.10% |
| Dec 31, 2022 | 6.28% |
| Sep 30, 2022 | -1.78% |
| Jun 30, 2022 | -13.14% |
| Mar 31, 2022 | -21.40% |
| Dec 31, 2021 | -25.02% |
| Sep 30, 2021 | -48.45% |
| Jun 30, 2021 | 14.69% |
| Mar 31, 2021 | 28.28% |